Pd. Marley et al., ACTIVATION OF TYROSINE-HYDROXYLASE BY PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP-27) IN BOVINE ADRENAL CHROMAFFIN CELLS, Journal of the autonomic nervous system, 60(3), 1996, pp. 141-146
The effect of pituitary adenylate cyclase-activating polypeptide (PACA
P-27) on tyrosine hydroxylase activity has been studied in intact, cul
tured, bovine adrenal chromaffin cells. Tyrosine hydroxylase activity
was determined in situ by measuring the production of (CO2)-C-14 follo
wing the hydroxylation and rapid decarboxylation of [C-14]tyr offered
to the cells. PACAP-27 increased tyrosine hydroxylase activity 3-fold
over 10 min, with an EC(50) of 10-20 nM. PACAP-38 was approximately 2-
fold less potent. Removing extracellular Ca2+ reduced basal tyrosine h
ydroxylase activity and the activation produced by both PACAP-27 and f
orskolin by about 20%. In the absence of extracellular Ca2+, chelation
of intracellular Ca2+ by treating cells with BAPTA-AM (50 mu M) cause
d a consistent 40-50% reduction in basal tyrosine hydroxylase activity
and in the responses to forskolin and PACAP-27. The tyrosine hydroxyl
ase activation produced by PACAP-27 was unaffected by the protein kina
se C inhibitor Ro 31-8220 (3 mu M), but was reduced by 85% by the prot
ein kinase A inhibitor H89 (10 mu M). PACAP-27 increased cellular cycl
ic AMP levels 3-fold at 100 nM. The results suggest that PACAP-27 acti
vates tyrosine hydroxylase in bovine chromaffin cells through cyclic A
MP formation and protein kinase A activation, and that both extracellu
lar and intracellular Ca2+ modulate the effect of the adenylate cyclas
e/cyclic AMP/protein kinase A signalling pathway on tyrosine hydroxyla
se activity.